Inactive
Notice ID:RFQ-FDA-CFSAN-2022-111986-1253985
This requirement is being solicited as a Sole Source Procurement, pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, (there is only...
This requirement is being solicited as a Sole Source Procurement, pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, (there is only one responsible source and no other supplies or services will satisfy agency requirements), using the Simplified Acquisition Procedures per FAR Subpart 13.5. The Food and Drug Administration (FDA) intends to award this Sole Source purchase order to Qiagen LLC.